Thu, January 4, 2018
Wed, January 3, 2018
Tue, January 2, 2018
Tue, December 26, 2017
Fri, December 22, 2017
Thu, December 21, 2017
Wed, December 20, 2017

Ami Fadia Initiated (TEVA) at Sell and Held Target at $15 on, Jan 2nd, 2018

Ami Fadia of Leerink Swann, Initiated "Teva Pharmaceutical Industries Limited" (TEVA) at Sell and Held Target at $15 on, Jan 2nd, 2018.

Ami has made no other calls on TEVA in the last 4 months.



There are 9 other peers that have a rating on TEVA. Out of the 9 peers that are also analyzing TEVA, 6 agree with Ami's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Risinger of "Morgan Stanley" Upgraded from Sell to Hold on, Friday, December 15th, 2017
  • Vamil Divan of "Credit Suisse" Upgraded from Sell to Hold on, Friday, December 15th, 2017
  • Rohit Vanjani of "Guggenheim" Initiated at Hold and Held Target at $16 on, Tuesday, December 12th, 2017
  • Liav Abraham of "Citigroup" Maintained at Hold with Decreased Target to $13 on, Monday, November 13th, 2017
  • Gregg Gilbert of "Deutsche Bank" Downgraded from Strong Buy to Hold on, Friday, November 3rd, 2017
  • Douglas Tsao of "Barclays" Maintained at Hold with Decreased Target to $19 on, Friday, October 20th, 2017


These are the ratings of the 3 analyists that currently disagree with Ami


  • Jami Rubin of "Goldman Sachs" Upgraded from Hold to Strong Buy on, Friday, December 15th, 2017
  • Chris Schott of "JP Morgan" Downgraded from Hold to Sell on, Monday, November 13th, 2017
  • Tim Chiang of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $24 on, Monday, September 11th, 2017